Mitral Valve Repair Reference Center at The Mount Sinai Hospital Mount Sinai Heart

Tricuspid Valve Repair for Treatment and Prevention of Secondary Tricuspid Regurgitation in Patients Undergoing Mitral Valve Surgery.

 

Ani C. Anyanwu, Joanna Chikwe, and David H. Adams

 

Current Cardiology Reports; Volume 10, Issue 2, March 2008, Pages 110-117

 

Secondary or functional tricuspid regurgitation occurring late after mitral valve surgery is associated with high morbidity and mortality. In this article, we review the pathophysiology of secondary tricuspid regurgitation and the evidence supporting the use of tricuspid valve annuloplasty for preventing and treating secondary tricuspid regurgitation. Liberal application of tricuspid valve annuloplasty is recommended to prevent progression of secondary regurgitation, as contrary to widely held opinion, fixing the left-sided valve dysfunction often does not resolve secondary tricuspid valve dysfunction. Based on existing literature, assessing the tricuspid valve annular dimensions can be recommended as part of all mitral valve operations, and annuloplasty strongly considered in patients with tricuspid annular dilatation or moderate to severe tricuspid regurgitation.

 

Full Text PDF

 

 

Surgical Management of Functional Tricuspid Regurgitation with a New Remodeling Annuloplasty Ring

 

Farzan Filsoufi, Sacha P. Salzberg, Vivian Abascal, David H. Adams

 

The Mount Sinai Journal of Medicine ; Volume 73, Number 6, October 2006, Pages 874-879

 

Moderate-to-severe functional tricuspid regurgitation (TR) should be corrected in patients undergoing surgery for left-sided valvular diseases, to improve long-term outcomes. Several techniques of surgical repair (suture annuloplasty or prosthetic annuloplasty) to correct this condition have been described. Multiple clinical studies have shown the superiority of prosthetic remodeling annuloplasty over the other surgical approaches.

 

Full Text PDF

 

 

A Three-Dimensional Ring Annuloplasty for the Treatment of Tricuspid Regurgitation

 

Farzan Filsoufi, Sacha P. Salzberg, Marianne Coutu and David H. Adams

 

The Annals of Thoracic Surgery; Volume 81, Issue 6, June 2006, Pages 2273-2277

 

Significant functional tricuspid regurgitation should be corrected in patients undergoing surgery for left-sided valvular diseases. Several clinical studies have shown the superiority of the remodeling annuloplasty over other repair techniques. Herein we report our early experience with a new three-dimensional remodeling prosthetic ring (Edwards MC3 annuloplasty system).

 

 

Optimal Surgical Management of Severe Tricuspid Regurgitation in Cardiac Transplant Patients

 

Farzan Filsoufi MD, Sacha P. Salzberg MD, Curtis A. Anderson MD, Gregory S. Couper MD, Lawrence H. Cohn MD and David H. Adams MD

 

The Journal of Heart and Lung Transplantation, Volume 25, Issue 3, March 2006, Pages 289-293

 

Severe tricuspid regurgitation (TR) with signs of right-sided heart failure is rare after orthotopic heart transplantation (OHT). In some instances, this condition will require surgical correction using reconstructive surgery or prosthetic valve replacement. Repair techniques of atrioventricular valves are now well described. However, the results of the different surgical procedures in this setting have not been widely reported and may depend on the type of valvular dysfunction and lesions present. Herein we report our experience in a group of patients requiring surgical correction of symptomatic severe TR after OHT.

 

 

Long-term outcomes of tricuspid valve replacement in the current era.

 

The Annals of Thoracic Surgery, Volume 80, Issue 3, September 2005, Pages 845-850

 

Farzan Filsoufi MD, Ani C. Anyanwu MD, Sacha P. Salzberg MD, Tim Frankel MD, Lawrence H. Cohn MD and David H. Adams MD

 

Regardless of the indication, tricuspid valve replacement (TVR) has historically been associated with high mortality and morbidity. We report the results of our experience in a high-risk patient population with an emphasis on operative mortality, long-term survival, and valve related events according to the type of prosthesis.

 

Page Created: Tuesday, 23 October 2007

Last Updated: Thursday, 07 August 2008

 

Department of Cardiothoracic Surgery | The Mount Sinai Medical Center | 1190 Fifth Avenue | New York, NY  10029 | 866-MITRAL5 (648-7255)

Home | Site Map | The Mount Sinai Hospital | Press | About This Site | Legal Statement | Privacy Policy | Contact Us
Copyright © 2009, The Mount Sinai Medical Center. All Rights Reserved. Site by Wang Media.

 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.